These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 26460696)
1. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival. Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696 [TBL] [Abstract][Full Text] [Related]
2. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors. Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100 [TBL] [Abstract][Full Text] [Related]
3. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis. Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464 [TBL] [Abstract][Full Text] [Related]
4. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma. Zhao G; Na R; Li L; Xiao H; Ding N; Sun Y; Han R Oncol Rep; 2017 Aug; 38(2):1021-1028. PubMed ID: 28656230 [TBL] [Abstract][Full Text] [Related]
5. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by Huang B; Huang M; Li Q Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187 [TBL] [Abstract][Full Text] [Related]
6. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650 [TBL] [Abstract][Full Text] [Related]
7. Vasohibin-1 suppresses colon cancer. Liu S; Han B; Zhang Q; Dou J; Wang F; Lin W; Sun Y; Peng G Oncotarget; 2015 Apr; 6(10):7880-98. PubMed ID: 25797264 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150 [TBL] [Abstract][Full Text] [Related]
9. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis. Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025 [TBL] [Abstract][Full Text] [Related]
10. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice. Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879 [TBL] [Abstract][Full Text] [Related]
11. Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma. Sano R; Kanomata N; Suzuki S; Shimoya K; Sato Y; Moriya T; Shiota M Tohoku J Exp Med; 2017 Oct; 243(2):107-114. PubMed ID: 29057763 [TBL] [Abstract][Full Text] [Related]
13. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment. Koyanagi T; Suzuki Y; Komori K; Saga Y; Matsubara S; Fujiwara H; Sato Y Cancer Sci; 2017 Mar; 108(3):512-519. PubMed ID: 28032401 [TBL] [Abstract][Full Text] [Related]
14. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis. Li Y; Xiao M; Guo F Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells. Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241 [TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels. Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394 [TBL] [Abstract][Full Text] [Related]
17. Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo. Kern J; Steurer M; Gastl G; Gunsilius E; Untergasser G BMC Cancer; 2009 Aug; 9():284. PubMed ID: 19682397 [TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion. Nonaka H; Saga Y; Fujiwara H; Akimoto H; Yamada A; Kagawa S; Takei Y; Machida S; Takikawa O; Suzuki M Int J Oncol; 2011 Jan; 38(1):113-20. PubMed ID: 21109932 [TBL] [Abstract][Full Text] [Related]
19. The vasohibin family: Novel regulators of angiogenesis. Sato Y Vascul Pharmacol; 2012; 56(5-6):262-6. PubMed ID: 22286022 [TBL] [Abstract][Full Text] [Related]
20. Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion. Suzuki Y; Kobayashi M; Miyashita H; Ohta H; Sonoda H; Sato Y J Cell Sci; 2010 Sep; 123(Pt 18):3094-101. PubMed ID: 20736312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]